07630.HK
Impact Therap-b
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 15.59
+4.07%Margins
Gross margin
80.1%
EBITDA margin
-583.1%
EBIT margin
-612.6%
Net margin
-770.6%
FCF margin
-261.9%
55.9%
Return on equity
-160.0%
Return on assets
443.3%
Return on invested capital
0.18x
Asset turnover
-HKD 200.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025